Concomitant use of bypassing agents with emicizumab for people with haemophilia A and inhibitors undergoing surgery-Reference-Cited by-同舟云学术

Concomitant use of bypassing agents with emicizumab for people with haemophilia A and inhibitors undergoing surgery

Author:

Jiménez‐Yuste Victor¹^ORCID,Rodríguez‐Merchán E. Carlos²^ORCID,Matsushita Tadashi³,Holme Pål Andrè⁴⁵

Affiliation:

1. Department of Hematology La Paz University Hospital‐IdiPaz, Autónoma University Madrid Spain

2. Osteoarticular Surgery Research La Paz University Hospital‐IdiPaz, Autónoma University Madrid Spain

3. Department of Transfusion Medicine Nagoya University Hospital Nagoya Japan

4. Department of Hematology Oslo University Hospital Oslo Norway

5. Institute of Clinical Medicine University of Oslo Oslo Norway

Funder

Novo Nordisk

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

Reference49 articles.

2. Tailoring care to haemophilia patients’ needs: which specialty and when?;Morfini M;Blood Transfus,2015

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献